PTBP1 variants displaying altered nucleocytoplasmic distribution are responsible for a neurodevelopmental disorder with skeletal dysplasia
Authors:
- Aymeric MassonAMAymeric Masson
- Julien PaccaudJPJulien Paccaud
- Martina OreficeMOMartina Orefice
- Estelle ColinECEstelle Colin
- Outi MäkitieOMOuti Mäkitie
- Valérie Cormier-DaireVCValérie Cormier-Daire
- Raissa RelatorRRRaissa Relator
- Sourav GhoshSGSourav Ghosh
- Jean-Marc StrubJSJean-Marc Strub
- Christine Schaeffer-ReissCSChristine Schaeffer-Reiss
- Carlo MarcelisCMCarlo Marcelis
- David A. KoolenDKDavid A. Koolen
Open Access
- 9 September 2025
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (22)
Abstract
Polypyrimidine tract-binding protein PTBP1 is a heterogeneous nuclear ribonucleoprotein primarily known for its alternative splicing activity. It shuttles between the nucleus and cytoplasm via partially overlapping N-terminal nuclear localization (NLS) and export (NES) signals. Despite its fundamental role in cell growth and differentiation, its involvement in human disease remains poorly understood. We identified 27 individuals from 25 families harboring de novo or inherited pathogenic variants — predominantly start-loss (89%) and, to a lesser extent, missense (11%) — affecting NES/NLS motifs. Affected individual presented with a syndromic neurodevelopmental disorder and variable skeletal dysplasia with disproportionate short-limbed short stature. Intellectual functioning ranged from normal to moderately delayed. Start-loss variants led to translation initiation from an alternative downstream in-frame methionine, resulting in loss of the NES and the first half of the bipartite NLS, and increased cytoplasmic stability. Start-loss and missense variants shared a DNA methylation episignature in peripheral blood and altered nucleocytoplasmic distribution in vitro and in vivo with preferential accumulation in processing bodies, causing aberrant gene expression but normal RNA splicing. Transcriptomic analysis of patient-derived fibroblasts revealed dysregulated pathways involved in osteochondrogenesis and neurodevelopment. Overall, our findings highlight a cytoplasmic role for PTBP1 in RNA stability and disease pathogenesis.Keywords
Funding Information
- PIA ANR (ISITE-BFC)
- European Commission (FEDER)
- Ministero della Salute (PNRR-MR1-2022-12376811)
- Italian Ministry of University and Research (FOE 2020)
- European Union’s Horizon 2020 (779257)
- Genome Canada and the Ontario Genomics Institute (OGI-188)
- French Investments for the Future Programme (A210019MS)
This publication has 77 references indexed in Scilit:
- Prediction whether a human cDNA sequence contains initiation codon by combining statistical information and similarity with protein sequencesBioinformatics, 2000
- Cooperative Assembly of an hnRNP Complex Induced by a Tissue-Specific Homolog of Polypyrimidine Tract Binding ProteinMolecular and Cellular Biology, 2000
- Gene Ontology: tool for the unification of biologyNature Genetics, 2000
- Isolation of a Mammalian Homologue of a Fission Yeast Differentiation RegulatorMolecular and Cellular Biology, 1999
- Sequence Determinants for hnRNP I Protein Nuclear LocalizationExperimental Cell Research, 1997
- The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K proteinThe EMBO Journal, 1997
- A Role for the M9 Transport Signal of hnRNP A1 in mRNA Nuclear ExportJournal of Cell Biology, 1997
- hnRNP PROTEINS AND THE BIOGENESIS OF mRNAAnnual Review of Biochemistry, 1993
- hnRNP 1, the polyprimidine tract-binding protein: distinct nuclear localization and association with hnRNAsNucleic Acids Research, 1992
- Characterization and molecular cloning of polypyrimidine tract-binding protein: a component of a complex necessary for pre-mRNA splicing.Genes & Development, 1991